Health News
FDA Warns of Contrast Agent Side Effect
FDA is advising that rare cases of underactive thyroid have been reported in infants following the use of contrast media containing iodine, also called “contrast dye,” for X-rays and other medical imaging procedures.
WHO Calls for Sustained Measles Vaccination
The World Health Organization (WHO) released some encouraging statistics on measles vaccination last week. But this news comes with a call to action.
Travel Vaccination FAQ
Traveling the world can be an eye-opening experience but, if you aren’t correctly prepared, it can be dangerous. Vaccinations are crucial but can be easily forgetten amidst the excitement of travel planning. Whether you're leaving the country for a few weeks or a few months, check out which vaccines you should be up-to-date on before you go.
Antibiotic Resistance: What Everyone Should Know
For years, patients often left the doctor's office with antibiotics for common ailments like colds or ear infections. But this practice might have led to a potentially dangerous new threat: antibiotic resistance.
The Antidote for Blood Thinners
Bleeding can be a major concern for patients taking blood thinners. But what if the effects of these drugs could be safely reversed in an emergency situation?
The Benefits of Insulin Pumps
Parents of kids with type 1 diabetes may now have an easier time with the debate surrounding the insulin pump.
Widely Used Antibiotics Linked to Heart Risk
A popular class of antibiotics used to treat common infections may carry some serious heart risks.
Natureal Recalled for Undeclared Ingredient
Bethesda, MD - Inaffit, LLC is voluntarily recalling all lots of Natureal light green and dark green capsules to the consumer level after FDA laboratory testing found Natureal to contain sibutramine.
Open Wide for Diabetes Awareness
November is National Diabetes Month, and this year’s theme is "Eat Well, America!"
Blood-Thinning Rx Had No Effect on Mortality
(US Food and Drug Administration): A U.S. Food and Drug Administration (FDA) review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart disease.